Bipolar Disorder
Â

Â
Introduction
 Unfortunately there are terrible side effects caused by psychiatric drugs (1). These side effects can cause artifacts in the search for biological markers, unfortunately. Biologial markers research should be done on patients who have never been given psychiatric drugs.
 A lot of studies have implicated aromatic amino acids in psychiatric diseases (2).
Â

Â
Introduction
 Unfortunately there are terrible side effects caused by psychiatric drugs (1). These side effects can cause artifacts in the search for biological markers, unfortunately. Biologial markers research should be done on patients who have never been given psychiatric drugs.
 A lot of studies have implicated aromatic amino acids in psychiatric diseases (2).
"This paper contains a review of published literature on aromatic amino acids in the context of physiological processes of the human body and chosen social disorders, such as cancers; psychiatric disorders: depression, anxiety states, schizophrenia, bipolar affective disorders; neurodegenerative, and cardiovascular diseases; chronic kidney insufficiency or diabetes." Krzy?ciak (Poland) Ref. 2.
Aromatic Amino Acids
Â
PhenylalanineÂ
 Hydrogens are shown as white balls. Carbons are purple. Bonds are grey. Nitrogen is green. Oxygen is orange.
"Tryptophan is also a very important amino acid because
two hormones, serotonin and melatonin, are synthesized
based on it."Â
 The entire article can be seen online ar Ref. 3. The article is a gem, but it is very technical.
Wirginia Krzy?ciak* (2)
*Department of Medical Diagnostics, Jagiellonian University, Medical College, Pharmacy Faculty, Kraków, Poland The entire article can be seen online ar Ref. 3. The article is a gem, but it is very technical.
"A significant
majority, around 94 % of tryptophan , is degraded
to kynurenine (KYN)." Krzy?ciak (3)
"Kynurenines, when generated in excessive amounts,
mostly demonstrate neurotoxic and neurodegenerative
action." Krzy?ciak (3)
Alzheimer's Disease
 Tryptophan metabolism appears to be abnormal in Alzheimer's disease (4).
Depression
 Ref. 5 implicates tryptophan metabolites in depression.Â
Â
Tryptophan
Alzheimer's Disease
 Tryptophan metabolism appears to be abnormal in Alzheimer's disease (4).
Depression
 Ref. 5 implicates tryptophan metabolites in depression.Â
Â
TryptophanTreatments
 Amino acids and other natural substances are used as treatments in orthomolecular psychiatry, sometimes called "psychodietetics" (6). Ref. 7 provides more information. My own website is Ref. 8.
Conclusions
 It appears that toxic metabolites of tryptophan in the kynurenine pathway cause the various forms of mental illness. Unfortunately psychiatric drugs cause very bad side effects including weight gain, diabetes, tremors, Parkisonism, etc. (1).
Therefore the best treatments are orthomolecular. Diets and supplements are used. However, psychosocial treatments do no harm.
References
1. Clin Schizophr Relat Psychoses. 2012 Jan;5(4):201-7. Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.
Weissman E, Jackson C, Schooler N, Goetz R, Essock S.
1. Clin Schizophr Relat Psychoses. 2012 Jan;5(4):201-7. Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.
Weissman E, Jackson C, Schooler N, Goetz R, Essock S.
2. Acta Biochim Pol. 2011;58(4):461-6. Epub 2011 Dec 15. Activity of selected aromatic amino acids in biological systems.
4. Bonda DJ, Mailankot M, Stone JG, Garrett MR, Staniszewska M, Castellani RJ, Siedlak SL, Zhu X, Lee H, Nagaraj RH, Smith MA (2010) Indoleamine 2,3-dioxygenase and 3OH-kynurenine modifications are found in the neuropathology of Alzheimer disease. Redox Rep 15: 161-168.
5. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new '5-HT' hypothesis of depression: Cell-mediated immune activaction induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 702-21.
5. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new '5-HT' hypothesis of depression: Cell-mediated immune activaction induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 702-21.
6. Cheraskin E, Ringsdorf WM and Brecher A. Psychodietetics. Bantam Books, 1974.
7. Hawkins D and Pauling L. Orthomolecular psychiatry, San Francisco: Freeman, 1973.
8. www.CraigOlson.bizhosting.com.
8. www.CraigOlson.bizhosting.com.
 Â
Credit
 These images are presented courtesy of Public Domain Clipart.
Â
Craig Olson
CraigEdwinOlson1@yahoo.com

 These images are presented courtesy of Public Domain Clipart.
Â
Craig Olson
CraigEdwinOlson1@yahoo.com








Comments: 13
Thanks for the information. That is a big molecule! :) You would probably like some of these drawing programs, Website.
If you don't mind, I would like to make the following statement.
As a patient, I am intimately aware of the negative side effects of pharmaceuticals and "chemicals" in general. As you may know, chemicals can be quite destructive to the human biological process. As such, even those that are "orthodox" can be dangerous. A person with a divergent metabolic pathway could be endangering their body if they consume a chemical, even natural, if it feeds that pathway and, as a consequence, causes production of a dangerous intermediate. As such, I am careful about consumption, and believe it is wise to talk to a physician before consuming excess chemicals, which include vitamins.
I have not studied the relationship of Tryptophan-Kynurenine, but I found an article and abstract of a review by Dr. Gregory F. Oxenkrug from Tufts University and Tufts Medical Center Usually, I do not trust one author and try to find competing and critical reviews. When I do this, I attempt to gain an understanding for the "initial" reasons of research. I am busy though so I leave that up to another reader. With that said, I did find the following. Some readers may find the information enjoyable. I only skimmed.
Oxenkrug, Gregory F., PhD. Tryptophan-Kynurenine Metabolism as a Common Mediator of Genetic and Environmental Impacts in Major Depressive Disorder: The Serotonin Hypothesis Revisited 40 Years Later. Isr J Psychiatry Relat Sci.[online]. 2010. vol 47(1). pp. 56-63. Available from: Article
Oxenkrug, Gregory F. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann NY Acad Sci.[online]. Jun 2010. Abstract Available from: Article
I also found a National Academies Press publication, "The Role of Protein and Amino Acids in Sustaining and Enhancing Performance", that very briefly discussed the kynurenine pathway and creation of diazo reactants that are excreted in the urine. I assume the later may allow a detection assay for kynurenine concentration, which may be associated with delirium in ICU patients, see below.
A Historical Perspective
Rapoport, Morton I; Beisel, William R. Curcadian Periodocity of tryptophan metabolism, 1968. J Clin Invest[online]. 2012. Available from: Article PMCID: PMC297241 doi: 10.1172/JCI105785
• The time of day can be important when evaluating tryptophan pathway.
Leklem, James E. Quantitative aspects of tryptophan metabolism in humans and other species: a review, June 1971. Am J Clin Nutrition[online]. vol. 24(6). pp. 659-672. Available from: Article
• The relationship between vitamin B6 and tryptophan metabolism is well established with regard to certain diseases and experimentally induced vitamin B6 deficiencies.
• Supplemental Vitamin B6 appears to influence the metabolic pattern of tryptophan degradation when a 2.0 gram or larger load of tryptophan is used.
- Vitamin B6 affects the pathway but I am not suggesting one take Vitamin B6. Rather, I am suggesting that one may be deficient.
Vitamin B6 and Memory
Oregon State University, Linus Pauling Institute: Micronutreinet Research for Optimum Health. Micronutrient Information Center. Vitamin B6. Ipi.oregonstate.edu[online]. 2012. Available from: Website
• Vitamin B6 deficiency is common among alcoholics but not common among the population.
• Severe vitamin B6 deficiency include irritability, depression, and confusion; additional symptoms include inflammation of the tohgue, sores or ulcers of the mouth, and ulcers of the skin at the corners of the mouth (2).
-Potential Cognitive effects associated with Vitamin B6 and B12.
--Higher levels of vitamin B6 may be interrelated with memory processes.
• Although deficiency of vitamin B6 is uncommon, marginal vitamin B deficiencies are relatively common in the elderly.
• Depression: Clinical Trials have not provided convincing evidence that vitamin B6 supplemental is an effective treatment for depression (24, 28), though vitamin B6 may have therapeutic efficacy in premenopausal women (28).
• Drug Interactions: Certain drugs can reduce vitamin B6 levels. Also, high doses of vitamin B6 have been found to decrease the efficacy of two anticonvulsants, phenobarbital and phenytoin, as well as L-Dopa (4, 24).
• See "Linus Pauling Institute Recommendation" on daily intake for young women, elderly, and others.
Kyurenine and Delirium?
MacMillan, Leigh. Pathways to delirium in the ICU, April 17, 2012. news.vanderbilt,edu[online]. 2012. Available from: Article
• "The findings demonstrate that increased kynurenine activation is associated with longer duration of acute brain dysfunction. The kynurenine pathway could be a therapeutic target for reducing delirium/coma in ICU patients."
..of the 10 that had the marker for bi polar6 had the disease, the other three, had either a sibling or parent with it....